TY - JOUR
T1 - Consonant intelligibility in individuals with Parkinson's disease in noise
T2 - Pre-specified secondary outcome variables from a randomized control trial (RCT) comparing two intensive speech treatments (LSVT LOUD vs. LSVT ARTIC)
AU - Schulz, Geralyn
AU - Halpern, Angela
AU - Speilman, Jennifer
AU - Ramig, Lorraine
AU - Panzer, Ira
AU - Sharpley, Alan
AU - Freeman, Katherine
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/8
Y1 - 2025/8
N2 - The majority of people with Parkinson's disease (PD) experience changes in speech production, most notably reduced vocal volume and imprecise articulation, that limit speech intelligibility and may contribute to significant declines in quality of life. We previously conducted a randomized control trial comparing two intensive treatments, voice (LSVT LOUD) or articulation (LSVT ARTIC) to assess single word intelligibility in the presence of background noise (babble and mall). Participants (64 PD and 20 Healthy) read words from the diagnostic rhyme test (DRT), an ANSI Standard for measuring intelligibility of speech, before and after one month (treatment or no treatment). Teams of trained listeners blindly rated the data. Previously we found that single word intelligibility in the presence of both noise conditions improved in PD participants who had LSVT LOUD compared to the groups that had LSVT ARTIC or no treatment. The current study analyzed the distinctive features (Compactness, Graveness, Sustention, Sibilation, Nasality, Voicing), of the initial consonants of words in the DRT test to determine what in particular is contributing to the differences in word intelligibility that we previously identified. The distinctive features of the DRT assess the valving nature of consonant production. Intensive treatment targeting vocal loudness (LSVT LOUD) had a greater positive effect on consonant intelligibility than treatment targeting articulation (LSVT ARTIC) for all distinctive features in background Babble noise and for 5/6 distinctive features in background Mall noise. Due to the definition of the distinctive features, we can conclude that the intelligibility gains seen following LSVT LOUD treatment are due to improved vocal tract valving.
AB - The majority of people with Parkinson's disease (PD) experience changes in speech production, most notably reduced vocal volume and imprecise articulation, that limit speech intelligibility and may contribute to significant declines in quality of life. We previously conducted a randomized control trial comparing two intensive treatments, voice (LSVT LOUD) or articulation (LSVT ARTIC) to assess single word intelligibility in the presence of background noise (babble and mall). Participants (64 PD and 20 Healthy) read words from the diagnostic rhyme test (DRT), an ANSI Standard for measuring intelligibility of speech, before and after one month (treatment or no treatment). Teams of trained listeners blindly rated the data. Previously we found that single word intelligibility in the presence of both noise conditions improved in PD participants who had LSVT LOUD compared to the groups that had LSVT ARTIC or no treatment. The current study analyzed the distinctive features (Compactness, Graveness, Sustention, Sibilation, Nasality, Voicing), of the initial consonants of words in the DRT test to determine what in particular is contributing to the differences in word intelligibility that we previously identified. The distinctive features of the DRT assess the valving nature of consonant production. Intensive treatment targeting vocal loudness (LSVT LOUD) had a greater positive effect on consonant intelligibility than treatment targeting articulation (LSVT ARTIC) for all distinctive features in background Babble noise and for 5/6 distinctive features in background Mall noise. Due to the definition of the distinctive features, we can conclude that the intelligibility gains seen following LSVT LOUD treatment are due to improved vocal tract valving.
KW - Dysarthria
KW - LSVT LOUD
KW - Motor speech disorders
KW - Parkinson's disease
KW - Treatment
UR - https://www.scopus.com/pages/publications/86000597846
U2 - 10.1016/j.jneuroling.2025.101251
DO - 10.1016/j.jneuroling.2025.101251
M3 - Article
AN - SCOPUS:86000597846
SN - 0911-6044
VL - 75
JO - Journal of Neurolinguistics
JF - Journal of Neurolinguistics
M1 - 101251
ER -